Onc Now | Episode 23
In this episode of Onc Now, host Jonathan Sackier is joined by Simon Lord, Associate Professor in Experimental Cancer Therapeutics, University of Oxford, UK, to discuss translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Lord brings a unique perspective on how the future of cancer therapy is being shaped today.
Apple | Spotify | Amazon Music (35 mins)
Simon Lord is an Honorary Consultant in Medical Oncology and Associate Professor in Experimental Cancer Therapeutics at the University of Oxford, UK. He works at the cutting edge of cancer drug development in the Early Phase Clinical Trials Unit, where his focus is on translating scientific breakthroughs into real-world treatments. With deep expertise in precision medicine and a passion for innovation in oncology, Professor Lord brings a unique perspective on how the future of cancer therapy is being shaped today.
Timestamps
1:04 – Quickfire question
11:26 – Metabolic imaging
15:26 – Insulin resistance
18:04 – Patient-specific biology
20:35 – Tamoxifen risks
21:57 – Metabolic interventions
24:46 – Lifestyle changes
27:04 – Clinical trials
29:44 – Wishes for healthcare
